Ligand Portfolio

We believe Ligand has assembled one of the largest portfolio of assets among its biotech peers with over 90 fully funded partnered programs.

The portfolio covers a diverse array of indications with many programs in late stages of development.



Pie Chart
Distribution of Therapeutic Areas
Oncology43%
CNS8%
Inflammation13%
Metabolic Disease7%
Blood Disorder8%
Anti-microbial5%
Anti-viral4%
Cardiology3%
Other4%
Distribution of Partners
GSK8
Merck4
Pfizer4
BMS4
AstraZeneca3
Sanofi Aventis2
Eli Lilly4



 

 

Site 'Main' Navigation: